<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">SANP</journal-id>
      <journal-title-group>
        <journal-title>Swiss Archives of Neurology, Psychiatry and Psychotherapy</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2297-7007</issn>
      <issn pub-type="ppub">2297-6981</issn>
      <publisher>
        <publisher-name>EMH Schweizerischer Ärzteverlag AG</publisher-name>
        <publisher-loc>Farnsburgerstrasse 8
CH-4132 Muttenz</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">03274</article-id>
      <article-id pub-id-type="doi">10.4414/sanp.2023.03274</article-id>
      <article-categories>
        <!-- rubric -->
        <subj-group subj-group-type="Article Type">
          <subject>Review article</subject>
        </subj-group>
        <!-- topics -->
        <subj-group subj-group-type="Classification">
          <subject>Neuroimmunology</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Neuropsychiatric symptoms of autoimmune limbic encephalitis, between neurology and psychiatry</article-title>
      </title-group>
      <contrib-group>
        <contrib id="author-1" contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid"/>
          <name>
            <surname>Dehmani</surname>
            <given-names>Sirine</given-names>
          </name>
          <email>sirinedehmanig@gmail.com</email>
          <aff>Neurorehabilitation Division, Fribourg Hospital, Meyriez/Murten</aff>
        </contrib>
        <contrib id="author-2" contrib-type="author" corresp="no">
          <contrib-id contrib-id-type="orcid"/>
          <name>
            <surname>Chabwine</surname>
            <given-names>Joelle  N.</given-names>
          </name>
          <email>joelle.chabwine@unifr.ch</email>
          <aff>Senior Clinician and Researcher | Neuroscience and Movement Science | Chemin du Musée 5 | Fribourg | 1700 | SWITZERLAND | +41789443230</aff>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub" date-type="pub" iso-8601-date="2023.04.19">
        <day>19</day>
        <month>04</month>
        <year>2023</year>
      </pub-date>
      <volume>174</volume>
      <issue>02</issue>
      <fpage>40</fpage>
      <lpage>43</lpage>
      <permissions>
        <copyright-statement>Copyright: EMH Schweizerischer Ärzteverlag AG</copyright-statement>
        <copyright-year>2023</copyright-year>
        <copyright-holder>EMH Schweizerischer Ärzteverlag AG</copyright-holder>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
          <license-p>"Swiss Archives of Neurology, Psychiatry and Psychotherapy" is an open access publication of EMH published in accordance with the terms of the Creative Commons licence attribution - NonCommercial - NoDerivatives 4.0 International. You are free to share, copy and redistribute the material in any medium or format under the following terms:</license-p>
          <license-p>Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.</license-p>
          <license-p>NonCommercial — You may not use the material for commercial purposes.</license-p>
          <license-p>NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.</license-p>
          <license-p>"Non-commercial" means not primarily intended for or directed towards commercial advantage or monetary compensation. The incorporation of publications in commercial products, the use of publications to advertise for commercial products or services and any other usage that directly or indirectly pursues commercial interests is subject to the express previous consent of the publishing house as part of a written agreement.</license-p>
          <license-p>Please send us your request in writing. Exact indication of the publication from which you would like to reproduce material and detailed information about its intended use help to facilitate and expedite request processing.</license-p>
        </license>
      </permissions>
      <abstract abstract-type="article" xml:lang="en">
        <p>Historically, a number of brain structures implicated in emotional regulation were commonly grouped under the umbrella of the “limbic system”. However, the conceptual definition, as well as the constitutive anatomy, and the function of the limbic system changed several times, as the brain knowledge evolved. The limbic system, initially defined as a “border” zone located at the edge of the encephalon, functionally lays also at a “clinical” border where psychiatry meets neurology. Limbic encephalitis (LE) illustrates well this concept. Indeed, although being an authentic neurological disease, its (early) psychiatric symptoms are increasingly being recognized and paid attention to. However, the heterogeneity of these symptoms (often falsely related to a purely psychiatric disease at initial stages) adds to the diagnosis difficulty, which often delays the right therapy and worsens the disease outcome.
While LE can be infectious (mainly herpetic) or autoimmune, through this narrative review, we aim1) to provide, as an introduction, a conceptual overview of the limbic system anatomy and function, and 2) to summarize the current understanding and management of the autoimmune LE and 3) to describe and analyze neuropsychiatric manifestations of autoimmune LE, as well as their treatment. We hope, that way, to help clinicians identifying and diagnosing(autoimmune) LE (especially early neuropsychiatric symptoms) with the shortest delay, in order to initiate appropriate treatment on time.</p>
      </abstract>
    </article-meta>
  </front>
  <body/>
  <back/>
</article>
